Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 3,454 | 4,089 | 3,484 | 3,217 | 2,812 |
| Operating Income | -3,454 | -4,089 | -3,484 | -3,217 | -2,812 |
| Other Income | -22 | 10 | 13 | 95 | -79 |
| Pre-tax Income | -3,476 | -4,079 | -3,471 | -3,122 | -2,891 |
| Net Income Continuous | -3,476 | -4,079 | -3,471 | -3,122 | -2,891 |
| Net Income | $-3,476 | $-4,079 | $-3,471 | $-3,122 | $-2,891 |
| EPS Basic Total Ops | -621.62 | -1,021.02 | -774.77 | -696.70 | -720.72 |
| EPS Basic Continuous Ops | -621.00 | -709.66 | -773.70 | -696.33 | -722.93 |
| EPS Diluted Total Ops | -621.62 | -1,021.02 | -774.77 | -696.70 | -720.72 |
| EPS Diluted Continuous Ops | -621.00 | -709.66 | -773.70 | -696.33 | -722.93 |
| EBITDA(a) | $-3,436 | $-2,837 | $-3,378 | $-3,115 | $-2,725 |